Market Research Report
Global In Vitro Diagnostic Market: Focus on Product, Test Type, Application, End User, Region and Competitive Landscape - Analysis and Forecast, 2020-2030
|Published by||BIS Research Inc.||Product code||951624|
|Published||Content info||287 Pages
Delivery time: 1-2 business days
|Global In Vitro Diagnostic Market: Focus on Product, Test Type, Application, End User, Region and Competitive Landscape - Analysis and Forecast, 2020-2030|
|Published: July 30, 2020||Content info: 287 Pages||
Global In Vitro Diagnostic Market to Reach $113.86 Billion by 2030
Market Report Coverage - In Vitro Diagnostic
Key Companies Profiled
Agilent Technologies, Inc., F. Hoffmann-La Roche, Illumina, Inc., Qiagen N.V., Abbott Laboratories, Inc., Thermo Fisher Scientific, Danaher Corporation, Myriad Genetics, Inc., Laboratory Corporation of America Holdings, Siemens Healthineers, Inc., Quest Diagnostics Incorporated, Bio-Rad Laboratories, Inc., Sysmex Corporation, bioMerieux S.A. Becton, Dickinson and Company, Ortho Clinical Diagnostics, Hologic, Inc, and DiaSorin S.p.A.
Key Questions Answered in this Report:
Healthcare experts have found IVD industry to be one of the most rapidly evolving markets and the global market for IVD is predicted to grow at a CAGR of 5.06% over the forecast period of 2020-2030. The market is driven by certain factors, which include rise in adoption of rapid, minimally invasive and non-invasive diagnostics tools & techniques, rise in the global geriatric population, high number of patients with infectious and chronic diseases, rise in the global healthcare expenditure, and rise in the demand for POC testing.
The market is favored by the development of rapid diagnostic instruments and consumables for several clinical areas, such as infectious disease, oncology/cancer, cardiology, HIV/AIDS, and nephrology, among others. Additionally, recent infectious disease outbreaks, such as COVID-19, have further propelled the growth of the global market.
Within the research report, the market is segmented on the basis of product, test type, application, end user, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.
The exponential rise in the application of precision medicine on the global level has created a buzz among companies to invest in the development of IVD to increase the accuracy and to ensure shorter turn-around time for disease diagnosis. Due to the diverse product portfolio and intense market penetration, F. Hoffmann-La Roche has been a pioneer in this field and has been a significant competitor in this market.
On the basis of region, North America holds the largest share of the global in vitro diagnostic market due to growing incidence of infectious disease and cancer, including its various types, increased focus on democratizing precision diagnostics for various applications, increasing geriatric population, and favorable government reimbursement policies in the region. Apart from this, the Asia-Pacific region is anticipated to grow at the fastest CAGR during the forecast period.
List of Tables
List of Figures